Franklin Biotechnology Discv Z(acc)GBP
Pricing frequency
Daily
Dealing cut off time
15:00
Type
SICAV
Yield
–
NAV
£66.71
Income frequency
-
Ongoing charge
1.31%
Latest actual NAV date
30-10-2026
ISIN
LU0774687577
UCITS
Yes
This fund can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment
Before investing please read:
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 30/09/2026 | % of assets |
|---|---|
| Jazz Pharmaceuticals PLC | 5.01 |
| Amgen Inc | 4.72 |
| Gilead Sciences Inc | 4.53 |
| Vertex Pharmaceuticals Inc | 3.98 |
| argenx SE ADR | 3.88 |
| Regeneron Pharmaceuticals Inc | 3.82 |
| Revolution Medicines Inc Ordinary Shares | 3.37 |
| Guardant Health Inc | 3.01 |
| AstraZeneca PLC | 2.97 |
| BridgeBio Pharma Inc | 2.53 |
Investment objective
The Fund's investment goal is to seek capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms located in the US and other countries and to a lesser extent in debt securities of any type of issuers worldwide.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.